Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2023

Open Access 01-01-2023 | Acute Lymphoblastic Leukemia | Research

Fatigue trajectories during pediatric ALL therapy are associated with fatigue after treatment: a national longitudinal cohort study

Authors: Elin Irestorm, Lindsay M. H. Steur, Gertjan J. L. Kaspers, Natasha K. A. Van Eijkelenburg, Inge M. Van der Sluis, Natasja Dors, Cor Van den Bos, Wim J. E. Tissing, Martha A. Grootenhuis, Raphaele R. L. Van Litsenburg

Published in: Supportive Care in Cancer | Issue 1/2023

Login to get access

Abstract

Objective

Fatigue is one of the most prevalent and distressing symptoms reported by survivors of childhood cancer. There is currently a lack of longitudinal studies on cancer-related fatigue, and especially on the relationship between the course of fatigue during treatment and fatigue at follow-up. The purpose of the current study was therefore to investigate if the course of fatigue during treatment, treatment intensity, serious adverse events, sex, or age at diagnosis are associated with cancer-related fatigue after treatment.

Methods

Participants were 92 children and adolescents diagnosed with acute lymphoblastic leukemia (mean age at diagnosis was 6.26 years). Fatigue was measured with PedsQL multidimensional fatigue scale proxy reports 5 months after diagnosis, 12 months after diagnosis, 24 months after diagnosis, and at follow-up 12 months after end of treatment. The effect of patient and treatment characteristics on fatigue reported at follow-up was tested through logistic regression analyses.

Results

The course of fatigue during treatment significantly predicted fatigue reported at follow-up for general fatigue (p = .038, OR = 9.20), sleep/rest fatigue (p = .011, OR = 15.48), and cognitive fatigue (p < .001, OR = 10.78). None of the other variables were associated with fatigue at follow-up for any of the subscales.

Conclusions

The findings demonstrate that fatigue reported during treatment can predict fatigue at follow-up. These results stress the need for longitudinal assessments. Healthcare professionals need to be aware that pediatric patients who are fatigued during treatment need to receive additional attention and timely interventions since cancer-related fatigue will not resolve by itself in the first year after end of treatment.
Literature
1.
Spathis A, Booth S, Grove S, Hatcher H, Kuhn I, Barclay S (2015) Teenage and young adult cancer-related fatigue is prevalent, distressing, and neglected: it is time to intervene. A systematic literature review and narrative synthesis. J Adolesc Young Adult Oncol 4(1):3–17CrossRef
2.
Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013) Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer 60(5):849–855CrossRef
3.
Meeske K, Patel S, Palmer SN, Nelson MB, Parow AM (2007) Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer 49(3):298–305CrossRef
4.
Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P et al (2013) Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst 105(19):1432–1440CrossRef
5.
Christen S, Roser K, Mulder RL, Ilic A, Lie HC, Loonen JJ et al (2020) Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. J Cancer Surviv 14(6):923–938CrossRef
6.
Irestorm E, Olsson IT, Johansson B, Øra I (2020) Cognitive fatigue in relation to depressive symptoms after treatment for childhood cancer. BMC Psych 8(1):1–9
7.
Gordijn MS, van Litsenburg RR, Gemke RJ, Huisman J, Bierings MB, Hoogerbrugge PM et al (2013) Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 60(3):479–485CrossRef
8.
van Deuren S, Penson A, van Dulmen-den Broeder E, Grootenhuis MA, van der Heiden-van der Loo M, Bronkhorst E, et al (2022) Prevalence and risk factors of cancer-related fatigue in childhood cancer survivors: A DCCSS LATER study. Cancer 128(5):1110–1121
9.
Steur L, Kaspers G, Van Someren E, Van Eijkelenburg N, Van der Sluis I, Dors N et al (2020) The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia. Support Care Cancer 28(12):5983–5993CrossRef
10.
Steur LM, Kaspers GJ, Van Someren EJ, Van Eijkelenburg NK, Van der Sluis IM, Dors N et al (2020) Sleep–wake rhythm disruption is associated with cancer-related fatigue in pediatric acute lymphoblastic leukemia. Sleep 43(6):zsz320CrossRef
11.
Warris LT, van den Heuvel-Eibrink MM, den Hoed MAH, Aarsen FK, Pieters R, van den Akker ELT (2014) Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? Syst Rev Pediatr Blood Cancer 61(7):1313–1318CrossRef
12.
Hinds PS, Hockenberry MJ, Gattuso JS, Kumar Srivastava D, Tong X, Jones H et al (2007) Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 110(10):2321–2330CrossRef
13.
van Deuren S, Boonstra A, van Dulmen-den Broeder E, Blijlevens N, Knoop H, Loonen J (2020) Severe fatigue after treatment for childhood cancer. Cochrane Database Syst Rev 3:Cd012681
14.
Iop A, Manfredi AM, Bonura S (2004) Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol 15(5):712–720CrossRef
15.
Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P (2002) The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer 94(7):2090–2106CrossRef
16.
Gordijn M, Cremers EM, Kaspers GJ, Gemke RJ (2011) Fatigue in children: reliability and validity of the Dutch PedsQL multidimensional fatigue scale. Qual Life Res 20(7):1103–1108CrossRef
17.
Puhr A, Ruud E, Anderson V, Due-Tonnesen BJ, Skarbo AB, Finset A et al (2019) Self-reported executive dysfunction, fatigue, and psychological and emotional symptoms in physically well-functioning long-term survivors of pediatric brain tumor. Dev Neuropsychol 44(1):88–103CrossRef
18.
Irestorm E, Ora I, Linge HM, Tonning OI (2021) Cognitive fatigue and processing speed in children treated for brain tumours. J Int Neuropsychol Soc 27:865–874CrossRef
19.
Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA Cancer J Clin 65(3):190–211CrossRef
20.
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D et al (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Canc Netw 13(8):1012–39CrossRef
21.
Cramp F, Byron‐Daniel J (2012) Exercise for the management of cancer‐related fatigue in adults. Cochrane Database Syst Rev 11(11):CD006145
22.
Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW (2004) Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 101(9):2116–2125CrossRef
23.
Hockenberry-Eaton M, Hinds PS (2000) Fatigue in children and adolescents with cancer: evolution of a program of study. Semin Oncol Nurs 16(4):261–72 (discussion 72-8)CrossRef
24.
Nap-van der Vlist MM, Dalmeijer GW, Grootenhuis MA, van der Ent K, van den Heuvel-Eibrink MM, Swart JF et al (2021) Fatigue among children with a chronic disease: a cross-sectional study. BMJ Paediatr Open 5(1):e000958CrossRef
25.
Hockenberry MJ, Pan W, Moore IMK, Scheurer ME, Taylor OA, Hooke MC et al (2018) Influence of nitrosative stress on fatigue during childhood leukemia treatment. Biol Res Nurs 20(4):403–409CrossRef
26.
Crabtree VM, Rach AM, Schellinger KB, Russell KM, Hammarback T, Mandrell BN (2015) Changes in sleep and fatigue in newly treated pediatric oncology patients. Support Care Cancer 23(2):393–401CrossRef
27.
Zeller B, Loge JH, Kanellopoulos A, Hamre H, Wyller VB, Ruud E (2014) Chronic fatigue in long-term survivors of childhood lymphomas and leukemia: persistence and associated clinical factors. J Pediatr Hematol Oncol 36(6):438–444CrossRef
28.
Daniel LC, Brumley LD, Schwartz LA (2013) Fatigue in adolescents with cancer compared to healthy adolescents. Pediatr Blood Cancer 60(11):1902–1907CrossRef
29.
Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK et al (2008) Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep 31(2):271–281CrossRef
30.
Goedendorp MM, Peters ME, Gielissen MF, Witjes JA, Leer JW, Verhagen CA et al (2010) Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist 15(10):1122CrossRef
31.
Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S et al (2012) Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med 10(3):202–216CrossRef
32.
Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH et al (2014) Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J Clin Oncol 32(6):557CrossRef
33.
Van Der Lee ML, Garssen B (2012) Mindfulness-based cognitive therapy reduces chronic cancer-related fatigue: a treatment study. Psychooncology 21(3):264–272CrossRef
34.
Crabtree VM, LaRosa KN, MacArthur E, Russell K, Wang F, Zhang H et al (2021) Feasibility and acceptability of light therapy to reduce fatigue in adolescents and young adults receiving cancer-directed therapy. Behav Sleep Med 19(4):492–504CrossRef
35.
Van Dijk-Lokkart EM, Steur LMH, Braam KI, Veening MA, Huisman J, Takken T et al (2019) Longitudinal development of cancer-related fatigue and physical activity in childhood cancer patients. Pediatr Blood Cancer 66(12):e27949
36.
Haverman L, Engelen V, van Rossum MA, Heymans HS, Grootenhuis MA (2011) Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application. BMC Pediatr 11(1):1–7CrossRef
37.
Crichton AJ, Babl F, Oakley E, Greenham M, Hearps S, Delzoppo C et al (2017) Prediction of multidimensional fatigue after childhood brain injury. J Head Trauma Rehabil 32(2):107–116CrossRef
38.
Nascimento LC, Nunes MD, Rocha EL, Bomfim EO, Floria-Santos M, Dos Santos CB et al (2015) High validity and reliability of the PedsQL multidimensional fatigue scale for Brazilian children with cancer. J Pediatr Oncol Nurs 32(1):57–64CrossRef
Metadata
Title
Fatigue trajectories during pediatric ALL therapy are associated with fatigue after treatment: a national longitudinal cohort study
Authors
Elin Irestorm
Lindsay M. H. Steur
Gertjan J. L. Kaspers
Natasha K. A. Van Eijkelenburg
Inge M. Van der Sluis
Natasja Dors
Cor Van den Bos
Wim J. E. Tissing
Martha A. Grootenhuis
Raphaele R. L. Van Litsenburg
Publication date
01-01-2023
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2023
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-022-07456-x

Other articles of this Issue 1/2023

Supportive Care in Cancer 1/2023 Go to the issue

Research

Dietary supplement use and recommendations for discontinuation in an integrative oncology clinic

Research

PENS approach for breaking bad news in the oncology outpatient setting: a real-world report

Review

Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies

Research

Perspectives of caregivers of older adults with acute myeloid leukemia during initial hypomethylating agents and venetoclax chemotherapy

Research

Influence of social and behavioral determinants on health-related quality of life among cancer survivors in the USA

Research

Coping with cancer: the role of different sources of psychosocial support and the personality of patients with cancer in (mal)adaptive coping strategies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits